#OctopusEffects, #Blender When you use Subdivision Surface Modifier, but you want some edges or faces to remain untouched, Edge Crease is the solution. Hope it is useful to you Thanks for watching ...

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and ...

Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets ...

Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...

Investors didn't seem to be in a forgiving mood with the company's quarterly and annual guidance. That morning, Vertex revealed that its total revenue was slightly over $192 million in the third ...

Aqara's Edge Hub M300 with Aqara Studio Connect software is a plug-and-play hardware-software solution that is tailored to serve residential properties, multi-family homes, and light commercial ...

Do you love to read online? Which format is your favorite? For me, it’s the EPUB format, which is one of the most widely supported formats for eBook readers. But if you love to read it on a browser ...

Vertex Pharmaceuticals (NASDAQ:VRTX) shares fell in premarket trading on Tuesday after the company's VX-993 failed to meet the primary endpoint in the Phase 2 pain study, offsetting a strong quarterly ...

Aug 4 (Reuters) - Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage trial failure and will not start a study for expanded use of ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...

Boston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR Therapeutics to develop the first CRISPR treatment approved by the U.S.

Vertex Rail Technologies opened in Wilmington in 2014 with promises of over 1,300 jobs and a $60 million investment. Despite initial optimism and orders, the company faced setbacks including federal ...